SEATTLE, WASHINGTON / ACCESS Newswire / October 8, 2025 / Aptevo Therapeutics ("Aptevo" or the "Company") (Nasdaq:APVO), a clinical-stage biotechnology…
- Clinical challenge: uncertainty in discharge and admission decisions for women at risk of preeclampsia- PreFree: the first CE-marked, multimodal…
The Naderi Center sees growing demand for revision rhinoplasty, with Dr. Shervin Naderi providing surgical and non-surgical solutions customized to…
ATLANTA, GEORGIA / ACCESS Newswire / October 8, 2025 / Rezolut LLC, a national leader in advanced diagnostic imaging, is…
Black Book Survey results reveal the twenty-five firms shaping the next generation of accountable care infrastructure released in orchestration with…
SCOTTSDALE, Ariz., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage…
Catalent gains global rights to evaluate certepetide and its analogs for use as SMARTag® payloads across multiple ADCs designed to…
Brings decades of leadership in laboratory testing, clinical diagnostics, payor strategy, and sales growth Extensive track record in commercializing advanced…
Launch Follows IM8’s Record Growth to $6.6 Million Monthly Revenue in September IM8 Accelerates Toward $100 Million ARR Milestone with…
PARAMUS, N.J., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton”), a clinical-stage biotechnology company transforming standard-of-care therapies with…